A newly synthesized substrate, 3-hydroxybutyrylglycyl-glycyl-glycine (3HB-GGG), was applied to the assay of ACEinhibiting activity to overcome the smaller selectivity and sensitivity of the conventional method. In this study, an ACEinhibiting assay was improved by the use of a water-soluble tetrazolium salt, 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate sodium salt (WST-1), for the detection of 3-hydroxybutyrate, derived from 3HB-GGG. The optimized conditions were as follows: 0.333 mM NAD + , 0.333 mM WST-1, 0.1 mM EDTA, 0.633 U ml -1 diaphorase, and 0.700 U ml -1 3-hydroxybutyrate dehydrogenase. The developed assay was efficiently applicable to evaluate the ACEinhibiting activity of practical ACE inhibitors.
Introduction
Angiotensin I-converting enzyme (ACE), a nonspecific dipeptidyl carboxypeptidase associated with the reninangiotensin system, plays an important role in the regulation of blood pressure. 1 An overactivity of ACE causes blood-pressure elevation and the pathogenic effects of hypertension. Therefore, the inhibition of ACE activity can contribute to the regulation of blood pressure and the prevention of related pathogeneses.
Recently, we proposed an ACE-inhibiting assay using a novel synthetic substrate, 3-hydroxybutyrylglycyl-glycyl-glycine (3HB-GGG). The proposed assay was more sensitive than the conventional method using hippuryl-histidyl-leucine (HHL) as a substrate. 2, 3 However, in the proposed method, the use of an Fkit for the determination of 3-hydroxybutyrate (3HB) resulted in high cost and a long reaction time. In addition, the manipulation of the F-kit was inconvenient because of the smaller dispersion of reagents due to the high viscosity of a potassium phosphate/triethanolamine buffer solution containing an octylphenol ethylene oxide condensate (Triton X-100, used to solubilize proteins and improve the solubility of formazan) 4, 5 when the assay reagents were mixed together. For these reasons, we tried to develop a more rapid, inexpensive, sensitive, and convenient assay for the detection of 3HB by using a watersoluble tetrazolium salt, 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate sodium salt (WST-1). Although the formazans of most tetrazolium salts, including iodonitrotetrazolium chloride (INT) of the F-kit, are extremely water insoluble; 5, 6 WST-1 formazan has a solubility greater than 0.1 M. 6 Thus, WST-1, which is easily reduced with NADH or other reducing agents to a yellow formazan that shows an absorption maximum at 438 nm, 6 is useful as a sensitive chromogenic indicator for NADH in the proposed assay. The principle of the present assay is shown in Scheme 1.
Experimental

Reagents and chemicals
Diaphorase (DI) (EC 1.6.99.2, 90 units/mg protein, from Clostridium Kluyveri) was purchased from Oriental Yeast Co. (Tokyo, Japan). 3-Hydroxybutyrate dehydrogenase (3HBDH) (EC 1.1.1.30, 140 units/mg, from Pseudomonas sp.) and aminoacylase (acylase I, EC 3.5.1.14, 4300 units/mg, from pig kidney) were purchased from Wako (Osaka, Japan). ACE (EC 3.4.15.1, 3.4 units/mg, from rabbit lung), ethylenediaminetetraacetic acid disodium salt dihydrate (EDTA), and D,L-b-hydroxybutyric acid sodium salt (D,L-3HB) were obtained from Sigma (St Louis, MO). WST-1 was obtained from Dojindo Laboratories (Kumamoto, Japan). 3HB-GGG was synthesized according to our previous report. 2 The F-kit was purchased from R-Biopharm (Darmstadt, Germany). ACE inhibitory drinks (Tokuho), including Tokuho A (0.034 mg ml -1 of Ile-Pro-Pro and Val-ProPro), Tokuho B (0.004 mg ml -1 of Val-Tyr), and Tokuho C (0.002 mg ml -1 of Val-Tyr), were purchased from local supermarkets. All of the reagents were of analytical reagent grade and were used without further purification. All solutions were prepared with water purified by a Milli-Q system (Millipore, Tokyo, Japan).
Generation of 3HB from 3HB-GGG and detection of 3HB using an F-kit
The reaction was performed according to a previous report. 2 Briefly, the enzymatic reaction was initiated by the additions of 50 ml of 0. 15 ml of an ACE inhibitor. The mixture was incubated at 37˚C for 30 min. During this incubation, the substrate, 3HB-GGG, was cut into 3HB-G and G-G, and then 3HB and G successively (Scheme 1). The yield of 3HB was monitored using the F-kit. The principle of the F-kit is as follows:
In the presence of 3HBDH, 3HB is oxidized by NAD + to acetoacetate (1) . In a reaction catalyzed by DI, the NADH converts INT into the formazan (2), which is measured at 492 nm after 30-min reaction at 25˚C.
Optimization of 3HB determination with WST-1
The substrate solution was prepared by dissolving the D,L-3HB in buffer (the concentration of D-isomer was 50% of the D,L-3HB concentration). After the additions of 95 U ml -1 DI and 70 U ml -1 3HBDH to a mixture containing D-3HB (0.05 mM), NAD + (0.333 mM), WST-1 (0.333 mM), and EDTA (0.1 mM), the reaction mixture was incubated at 25˚C for 30 min. During this process, the absorbance change was measured at 438 nm using an Ultrospec 3000 UV-Visible spectrophotometer (GE Healthcare, Sweden). All reagents were dissolved in the buffer, and the concentrations of the reagents were expressed as those of the final mixture solutions. All assays were performed in triplicate.
Application of the proposed ACE-inhibiting assay to evaluate ACE inhibitors
ACE inhibitors including captopril, lisinopril, Val-Tyr and Tokuho products were used to evaluate the ACE-inhibiting activity. Each ACE inhibitor solution (15 ml) was added to a mixture containing 125 ml of 12.35 mM 3HB-GGG, 50 ml of 0.2 U ml -1 ACE, and 20 ml of 172 kU ml -1 aminoacylase, and then incubated at 37˚C for 30 min. Next, a reaction solution containing 3HB (100 ml) was used as a sample for a colorimetric assay of 3HB with WST-1 (described above). The inhibitory activities of ACE inhibitors were calculated as IC50 values.
Results and Discussion
As shown in Scheme 1, D-3HB generated from 3HB-GGG was oxidized into acetoacetate by the action of 3HBDH. At the same time, the cofactor, NAD + , was converted into the reduced form, NADH. During the oxidation of NADH to NAD + by DI, WST-1 was reduced to WST-1 formazan, which could be monitored spectrophotometrically at 438 nm. The formation of WST-1 formazan was stoichiometrically equal to D-3HB in the reaction mixture. The assay conditions were optimized in terms of the conversion ratio of D-3HB (%), calculated based on the molar extinction coefficient of WST-1 formazan at 438 nm (e = 3.7 ¥ 10 4 M -1 cm -1 ). 6 In this study, the concentration of D-3HB used for optimizations was fixed at 0.05 mM. This concentration was abundant compared with the concentration of D-3HB (0.015 mM, measured by the F-kit) generated from 3HB-GGG by the actions of ACE and aminoacylase after a reaction at 37˚C for 30 min, in order to ensure complete conversion. On the other hand, EDTA was added because it could eliminate the effect of metal ions and act as an ACE inhibitor. 7 To optimize the assay conditions, the pH dependence of the conversion of D-3HB, the influence of DI on the conversion of NADH, and the effect of 3HBDH and WST-1 on the conversion of 3HB were studied. To determine the pH dependence of 3HBDH and DI, the change in the conversion ratio of 3HB was examined at pH 7.0 -10.5 using 50 mM phosphate buffer (pH 7.0, 7.5, and 8.0), 50 mM pyrophosphate buffer (pH 8.5 and 9.0), and 50 mM carbonate buffer (pH 9.5, 10.0, 10.2, and 10.5). Figure 1 shows the influence of the pH on the conversion ratio of 0.05 mM D-3HB after a 10-min reaction. In this study, 10-min incubation was chosen as the reaction time, because the conversion ratio of 3HB rapidly reached a plateau after 10 min at pH 7.0 -9.0 (data not shown). Among the examined pH values, high conversion ratios (98 -104%) were observed at pH 8.0 -9.0. The conversion ratio fell drastically when the reaction pH was above 9.0 because of a decrease in the activity of DI in such an alkaline medium. 8 The conversion ratios of 3HB at pH 8.5 and pH 9.0 slightly exceeded 100% due to the calculation method using the molar extinction coefficient of WST-1, which might vary from pH to pH, since a pH-dependent color change is characteristic to sulfonated tetrazolium salts. 6 Although the conversion ratio at pH 8.0 was slightly lower than those at pH 8.5 and 9.0, it reached 98% after 10 min. In addition, the velocity of the enzymatic reaction at pH 8.0 was the highest for the examined pHs (data not shown). As a result, pH 8.0 was selected to be the optimum condition for subsequent experiments.
The effect of the DI concentration on the conversion ratio of NADH (0.05 mM) was examined in the range of 0.032 -0.633 U ml -1 DI (Fig. 2) . In consecutive enzyme reactions, it was the indicator reaction subsequent to the first reaction by 3HBDH. As shown in Fig. 2 , the conversion ratio of NADH increased, depending on the concentration of DI, and then turned to a plateau when the DI concentration was over 0.190 U ml -1 . At higher DI concentrations, NADH was completely converted within 10 min. On the other hand, the indicator reaction should achieve a steady state in as short a time as possible to accelerate consecutive enzyme reactions.
Therefore, the maximum concentration of DI (0.633 U ml -1 ) was chosen as the optimum condition for the assay.
With the optimized concentration of DI (0.633 U ml -1 ), the influence of the 3HBDH concentration (0.117 -0.700 U ml -1 ) on the conversion of D-3HB was examined (Fig. 3) . The conversion ratio of D-3HB initially depended on the enzyme concentration, but it tended to level off when the concentration of 3HBDH exceeded 0.300 U ml -1 . Above this concentration of 3HBDH, the conversion was almost 100% within 10 min. At the maximum 3HBDH concentration, 0.700 U ml -1 , the reaction velocity was the highest (a greatly stable plateau was observed within 5 min; data not shown). As a result, 0.700 U ml -1 3HBDH was adopted to be the optimum condition for the assay.
From an economical point of view, the consumption of WST-1 should be reduced, but the concentration of WST-1 must be excessive to enhance the equilibrium of the reaction toward the right side. Hence, the effect of the WST-1 concentration (0.1 -1.0 mM) on the conversion ratio of D-3HB was investigated (Fig. 4) . As shown, the conversion ratio of D-3HB increased with an increase in the concentration of WST-1, and then leveled off (96%) at a WST-1 concentration above 0.333 mM. In addition, the reaction velocity was constant at 0.333 -1.000 mM WST-1 (data not shown). Accordingly, 0.333 mM WST-1 was selected for optimizing the assay conditions. Consequently, the assay of 3HB with WST-1 was optimized as follows: a mixture solution (3.0 ml, pH 8.0) containing 100 ml of sample (3HB derived from 3HB-GGG), 0.333 mM NAD + , 0.333 mM WST-1, 0.1 mM EDTA, 0.633 U ml -1 DI, and 0.700 U ml -1 3HBDH was incubated at 25˚C. After 10 min, the WST-1 formazan was measured at 438 nm. The developed assay was sensitive, with a detection limit of 0.002 mM D-3HB, similar to that of the F-kit. Besides, the reproducibility (CV = 2.6%, n = 3) was relatively satisfactory for a colorimetric assay. In addition, the optimized assay was rapid (10 min, 3-fold shorter than that of the F-kit), economical (the cost per one determination with WST-1 was 3-fold lower than that with the F-kit). There is no doubt that the optimized assay of 3HB could be applied to determine serum 3HB, which indicates the status of diabetes mellitus in the field of diagnosing pathogenesis. 9 Finally, the developed method was applied to practical ACEinhibiting samples. The obtained IC50 values by the developed method using 3HB-GGG and the conventional method using HHL are listed in Table 1 . As can be seen in Table 1 , the IC50s of all samples could be evaluated by the developed method. In addition, a significant linearity was recognized between the developed method and the conventional method (r = 0.997, n = 6, p <0.01). In our experiment, the reproducibility of the developed method, shown as the RSD of the IC50 values, was superior to the reproducibility of the conventional method. Moreover, the IC50 values recognized in the developed method tended to be lower than those in the conventional method, indicating that the developed method had a higher sensitivity. These advantages of the developed assay will help precisely detect the inhibitory activity of ACE inhibitors, even at a minor concentration in order to screen potential inhibitors effectively. So far, many reports about the IC50 values of pure ACEinhibiting compounds have been published. Those values measured by the conventional method with HHL are also given in Table 1 for the purpose of a comparison. [10] [11] [12] [13] [14] [15] [16] [17] [18] The published data were over a wide range because the IC50 values were influenced by various factors, including the method conditions, the source of the enzyme, the calculation method, and the relationship between the inhibitor and the enzyme source. 1, 11 Thus, it was difficult to compare the data directly, but the IC50 values recognized in this study did not differ vastly from the published data. Besides, there were some differences in the values of Tokuho A and C between the two methods. This might have been interferences caused by unhydrolyzed HHL and food components in Tokuho products, which were easily extracted by ethyl acetate, and absorbed ultraviolet light at 228 nm in the conventional method. The use of a severe heating condition during evaporation of the extracting solvent might generate unexpected reaction products, which would also cause interferences. Because Tokuho A and C contained various food ingredients other than ACE-inhibiting peptides, there was a high possibility that the interference in the conventional method was caused by food ingredients. Thus, the developed method using 3HB-GGG and WST-1 at more selective wavelengths without any extracting or heating step would diminish the less reducibility as well as any unspecific absorption. These results revealed that the developed ACE-inhibiting method could be applied to the evaluation of practical ACE-inhibiting samples derived from various origins. It was suggested that the present ACE-inhibiting activity assay could be used instead of the conventional assay in the field of hypertension control.
Furthermore, the efficiency of the ACE inhibitory assay will be intensified when the present assay is applied to a flow-injection analysis system with immobilized enzymes. 
